A new glucose monitoring option

,; ,

Applied Evidence

A new glucose monitoring option

J Fam Pract. 2010 February;59(2):81-88

PDF Download

References

1. Dexcom. The new SEVEN PLUS. Available at: www.dexcom.com. Accessed January 6, 2010.

2. FreeStyle Navigator Continuous Glucose Monitoring System Available at: www.freestylenavigator.com. Accessed January 6, 2010.

3. Medtronic Diabetes Available at: www.minimed.com. Accessed January 6, 2010.

4. Garg S, Zisser H, Schwartz S, et al. Improvement in glycemic excursions with a transcutaneous, real time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29:44-50.

5. Weinstein R, Schwartz S, Bragz R, et al. Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System. Diabetes Care. 2007;30:1125-1130.

6. Garg S, Smith J, Beatson C, et al. Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems. Diabetes Technol Ther. 2009;11:65-72.

7. Medtronic User Guide, Guardian Real-Time Continuous Glucose Monitoring System. Appendix A: Sensor Accuracy, pp. 131-146. Available at: www.medtronicdiabetes.com/pdf/guardian_real_time_user_guide.pdf. Accessed January 11, 2010.

8. FDA Approves Abbott’s FreeStyle Navigator Continuous Glucose Monitoring System Available at: www.abbottdiabetescare.com/adc_dotcom/url/content/en_US/10.10:10/
general_content/General_Content_0000163.htm. Accessed January 6, 2010.

9. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1C-independent risk factor for diabetic complications. JAMA. 2006;295:1707-1708.

10. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications. 2005;19:178-181.

11. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681-1687.

12. DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet. 1999;354:617-621.

13. Donahue RP, Abbott RD, Reed DM, et al. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes. 1987;36:689-692.

14. Temelkova-Kurktschiev TS, Koehler C, Henkl E, et al. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1C level. Diabetes Care. 2000;23:1830-1834.

15. Kilpatrick ES, Rigby AS, Goode K, et al. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycemia in type 1 diabetes. Diabetologia. 2007;50:2553-2561.

16. Chetty VT, Almulla A, Odueyungbo A, et al. The effect of subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HbA1c) levels in type 1 diabetic patients: a systematic review. Diabetes Res Clin Pract. 2008;81:79-87.